BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15173513)

  • 1. Is it time to reduce our phobia of inhaled corticosteroids?
    Bahna SL
    Pediatrics; 2004 Jun; 113(6):1813-4. PubMed ID: 15173513
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma.
    Bacharier LB; Raissy HH; Wilson L; McWilliams B; Strunk RC; Kelly HW
    Pediatrics; 2004 Jun; 113(6):1693-9. PubMed ID: 15173493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023).
    Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Nicolaidou P
    J Pediatr Endocrinol Metab; 2007 Feb; 20(2):261; author reply 261-2. PubMed ID: 17396445
    [No Abstract]   [Full Text] [Related]  

  • 4. A Case of a Post-Operative Addisonian Crisis from HPA Axis Suppression from Inhaled Corticosteroids.
    Allen G; Mitchell A; Ramirez M; Holsten S; Shah N
    Am Surg; 2019 Sep; 85(9):e483-e484. PubMed ID: 31638547
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy.
    Livanou T; Ferriman D; James VH
    Lancet; 1967 Oct; 2(7521):856-9. PubMed ID: 12387243
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
    J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis.
    Allen DB
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):537-9. PubMed ID: 12487216
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic effects of inhaled corticosteroids.
    Monson JP
    Thorax; 1993 Oct; 48(10):955-6. PubMed ID: 8256240
    [No Abstract]   [Full Text] [Related]  

  • 10. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications.
    Wolthers OD; Honour JW
    J Asthma; 1999 Sep; 36(6):477-86. PubMed ID: 10498042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary cortisol monitoring: determination of reference values in healthy children and application in asthmatic children.
    Nagakura T; Tanaka T; Arita M; Nishikawa K; Shigeta M; Wada N; Matsumoto T; Hiraba K; Fukuda N
    Allergy Asthma Proc; 2012; 33(4):362-9. PubMed ID: 22856637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma.
    Irani AM; Cruz-Rivera M; Fitzpatrick S; Hoag J; Smith JA
    Ann Allergy Asthma Immunol; 2002 Mar; 88(3):306-12. PubMed ID: 11926625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
    Gulliver T; Eid N
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled steroids - too much of a good thing?
    Wilson JW; Robertson CF
    Med J Aust; 2002 Sep; 177(6):288-9. PubMed ID: 12225273
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled glucocorticoid therapy in children: how much is safe?
    Kamada AK; Parks DP; Szefler SJ
    Pediatr Pulmonol; 1992 Feb; 12(2):71-2. PubMed ID: 1570191
    [No Abstract]   [Full Text] [Related]  

  • 18. [Theory and practice with inhalation steroids--systemic effects and side effects].
    Morr H
    Pneumologie; 1991 Mar; 45(3):85-9. PubMed ID: 2031048
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
    Clark DJ; Lipworth BJ
    Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.